8-OH-Dpat
CAS No. 78950-78-4
8-OH-Dpat ( 8-Hydroxy-DPAT )
Catalog No. M17596 CAS No. 78950-78-4
8-OH-Dpat is a serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
Purity : 96%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 35 | In Stock |
|
10MG | 50 | In Stock |
|
25MG | 102 | In Stock |
|
50MG | 160 | In Stock |
|
100MG | 244 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product Name8-OH-Dpat
-
NoteResearch use only, not for human use.
-
Brief Description8-OH-Dpat is a serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
-
Description8-OH-Dpat is a serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
-
Synonyms8-Hydroxy-DPAT
-
PathwayAngiogenesis
-
TargetCDK
-
Recptor5-HT1A,5-HT7
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number78950-78-4
-
Formula Weight247.38
-
Molecular FormulaC16H25NO
-
Purity96%
-
SolubilityDMSO : ≥ 155 mg/mL; 626.57 mM
-
SMILESCCCN(CCC)C2Cc1c(cccc1O)CC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Dalpiciclib
Dalpiciclib is a highly selective, orally bioavailable, and comparable potency inhibitor of CDK4 and CKD6 with IC50s of 12.4?nM and 9.9?nM, respectively.
-
LEE011
LEE011 is an orally available, and highly specific CDK4/6 inhibitor. Phase 3.
-
PNU-112455A
PNU-112455A is an ATP-competitive CDK2/5 inhibitor with Ki of 2 uM and 2 uM for cdk2·GST-cyclin E and cdk5·GST-p25 respectively.